{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:13:10Z","timestamp":1684555990617},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/nrclinonc.2009.159","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T09:49:14Z","timestamp":1256723354000},"page":"624-626","source":"Crossref","is-referenced-by-count":1,"title":["Follicular lymphoma: maintenance therapy is (often) indicated"],"prefix":"10.1038","volume":"6","author":[{"given":"John F.","family":"Seymour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrclinonc2009159_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/1097-0142(19880201)61:3<441::AID-CNCR2820610306>3.0.CO;2-N","volume":"61","author":"WP Steward","year":"1988","unstructured":"Steward, W. P.  et al. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors. Cancer 61, 441\u2013447 (1988).","journal-title":"Cancer"},{"key":"BFnrclinonc2009159_CR2","first-page":"2215","volume":"23","author":"AZS Rohatiner","year":"2005","unstructured":"Rohatiner, A. Z. S.  et al. Meta-analysis to evaluate the role of interferon in follicular lymphoma. J. Clin. Oncol. 23, 2215\u20132223 (2005).","journal-title":"Oncol."},{"key":"BFnrclinonc2009159_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/1097-0142(19870715)60:2<156::AID-CNCR2820600205>3.0.CO;2-K","volume":"60","author":"EZ Ezdinli","year":"1987","unstructured":"Ezdinli, E. Z.  et al. The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma. Cancer 60, 156\u2013160 (1987).","journal-title":"Cancer"},{"key":"BFnrclinonc2009159_CR4","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","volume":"103","author":"M Ghielmini","year":"2004","unstructured":"Ghielmini, M.  et al. Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly \u00d74 schedule. Blood 103, 4416\u20134423 (2004).","journal-title":"Blood"},{"key":"BFnrclinonc2009159_CR5","first-page":"1088","volume":"23","author":"JD Hainsworth","year":"2005","unstructured":"Hainsworth, J. D.  et al. Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma\u2014a randomized phase II trial of the Minnie Pearl Cancer Research Network. J. Clin. Oncol. 23, 1088\u20131095 (2005).","journal-title":"Oncol."},{"key":"BFnrclinonc2009159_CR6","first-page":"1607","volume":"27","author":"H Hochster","year":"2009","unstructured":"Hochster, H.  et al. Maintenance rituximab after cyclophosphamide, vincristine and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 study. J. Clin. Oncol. 27, 1607\u20131614 (2009).","journal-title":"Oncol."},{"key":"BFnrclinonc2009159_CR7","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","volume":"108","author":"MHJ van Oers","year":"2006","unstructured":"van Oers, M. H. J.  et al. Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood 108, 3295\u20133301 (2006).","journal-title":"Blood"},{"key":"BFnrclinonc2009159_CR8","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"R Forstpointner","year":"2006","unstructured":"Forstpointner, R.  et al. Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood 108, 4003\u20134008 (2006).","journal-title":"Blood"},{"key":"BFnrclinonc2009159_CR9","first-page":"248","volume":"101","author":"L Vidal","year":"2009","unstructured":"Vidal, L.  et al. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J. Natl Cancer Inst. 101, 248\u2013255 (2009).","journal-title":"Inst."},{"key":"BFnrclinonc2009159_CR10","first-page":"320","volume":"9","author":"E Gajraj","year":"2008","unstructured":"Gajraj, E., Chung, H., Longson, C. & Stevens, A. Rituximab for follicular non-Hodgkin lymphoma. Lancet Oncol. 9, 320\u2013321 (2008).","journal-title":"Oncol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:02:34Z","timestamp":1684468954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2009.159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFnrclinonc2009159"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2009.159","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}